192 related articles for article (PubMed ID: 18201448)
41. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.
Csernok E; Holle J; Hellmich B; Willem J; Tervaert C; Kallenberg CG; Limburg PC; Niles J; Pan G; Specks U; Westman K; Wieslander J; De Groot K; Gross WL
Rheumatology (Oxford); 2004 Feb; 43(2):174-80. PubMed ID: 14585921
[TBL] [Abstract][Full Text] [Related]
42. [Neutrophil anticytoplasmic antibodies: their diagnostic utility in vasculitis and glomerulonephritis].
Bosch X; Mirapeix E; Font J; López-Soto A; Rodríguez R; Vivancos J; Revert L; Ingelmo M; Urbano-Márquez A
Med Clin (Barc); 1994 Mar; 102(11):412-7. PubMed ID: 8182997
[TBL] [Abstract][Full Text] [Related]
43. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.
Sanders JS; Huitma MG; Kallenberg CG; Stegeman CA
Rheumatology (Oxford); 2006 Jun; 45(6):724-9. PubMed ID: 16399845
[TBL] [Abstract][Full Text] [Related]
44. Analysis of Antineutrophil Cytoplasm Antibody from 118 730 Patients in Tertiary Hospitals in Jiangxi Province, China.
Tan L; Jiao A; Chen J; Feng X; Xu L; He S; Tan F; Jiang Y; Luo H; Li H; Wu Y; Tian Y; Zeng T; Yu J; Cao L; Zheng J; Xu H; Wei M; Gan W; Peng W; Liu Y; Hou J; Xu J; Shuai L; Huang W; Huang J; Lin Y; Liu J
Med Sci Monit; 2017 Sep; 23():4312-4320. PubMed ID: 28878204
[TBL] [Abstract][Full Text] [Related]
45. Antineutrophil cytoplasmic autoantibody in the absence of Wegener's granulomatosis or microscopic polyangiitis: implications for the surgical pathologist.
Gal AA; Velasquez A
Mod Pathol; 2002 Mar; 15(3):197-204. PubMed ID: 11904336
[TBL] [Abstract][Full Text] [Related]
46. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
47. Anti-neutrophil cytoplasmic antibodies (ANCA) in the clinical forms of leprosy.
Freire BF; Ferraz AA; Nakayama E; Ura S; Queluz TT
Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):475-82. PubMed ID: 10347568
[TBL] [Abstract][Full Text] [Related]
48. An index for renal outcome in ANCA-associated glomerulonephritis.
Vergunst CE; van Gurp E; Hagen EC; van Houwelingen HC; Hauer HA; Noël LH; Waldherr R; Ferrario F; van der Woude FJ; Bruijn JA; Bajema IM;
Am J Kidney Dis; 2003 Mar; 41(3):532-8. PubMed ID: 12612975
[TBL] [Abstract][Full Text] [Related]
49. [Retrospective study of 97 ANCA-positive patients: epidemiologic and clinical spectrum].
Covic A; Mutică C; Ignat A; Boaru I; Veisa G; Gusbeth-Tatomir P; Enea M; Covic M
Rev Med Chir Soc Med Nat Iasi; 2004; 108(2):305-10. PubMed ID: 15688804
[TBL] [Abstract][Full Text] [Related]
50. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Positive Otitis Media and Rhinosinusitis With Pathological Features of Immunoglobulin G4-Related Disease: A Case Report.
Ohno K; Matsuda Y; Arai T; Sugihara T; Iga S; Kimura Y
Ann Otol Rhinol Laryngol; 2016 Jun; 125(6):516-21. PubMed ID: 26747629
[TBL] [Abstract][Full Text] [Related]
51. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance.
Font J; Ramos-Casals M; Cervera R; Bosch X; Mirapeix E; García-Carrasco M; Morlà RM; Ingelmo M
Br J Rheumatol; 1998 Dec; 37(12):1287-91. PubMed ID: 9973150
[TBL] [Abstract][Full Text] [Related]
52. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
53. Higher antineutrophil cytoplasmic antibody (C-ANCA) titers are associated with increased overall healthcare use in patients with sinonasal manifestations of granulomatosis with polyangiitis (GPA).
Janisiewicz AM; Klau MH; Keschner DB; Lehmer RR; Venkat KV; Medhekar SS; Chang PK; Badran K; Leary R; Garg R; Nguyen AA; Lee JT
Am J Rhinol Allergy; 2015; 29(3):202-6. PubMed ID: 25975251
[TBL] [Abstract][Full Text] [Related]
54. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
Sinclair D; Stevens JM
Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
[TBL] [Abstract][Full Text] [Related]
55. ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective.
Falk RJ; Nachman PH; Hogan SL; Jennette JC
Semin Nephrol; 2000 May; 20(3):233-43. PubMed ID: 10855933
[TBL] [Abstract][Full Text] [Related]
56. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
57. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
59. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
Bakashvili N; Swaak AJ; Tervaert JW; Dees A
Ned Tijdschr Geneeskd; 2008 Apr; 152(17):1009-14. PubMed ID: 18549177
[TBL] [Abstract][Full Text] [Related]
60. [Diagnostic and pathogenic significance of antineutrophil cytoplasmic antibodies in vasculitides].
Bartůnková J; Tesar V; Fucíková T; Janatková I; Zabka J; Krystůfková O; Rychlík I
Bratisl Lek Listy; 1995 Oct; 96(10):528-33. PubMed ID: 8620323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
